IBO: Bagan rega target Impact BioMedical Inc

The share price history of Impact BioMedical Inc (IBO) on the GURU.Markets platform currently stands at 0.00. Business success relies on the demand for new hygiene products and the legal clarity of development rights. Impact BioMedical Inc (IBO) creates a diverse range of medications through partnerships with scientific centers and acquires patents in the field of antivirus software. Since the holding company has not yet entered the sales market, its capitalization is based exclusively on the value of its intellectual assets.

IBO Bagan rega target Impact BioMedical, Inc. (17.09.2024 - 22.10.2026)

Rincian analitis perusahaan Impact BioMedical (IBO)

Indikator analitis utama Impact BioMedical, Inc. (IBO):
Bagan bursa impactbiomedinc.com|IBO - Prakiraan konsensus analis|Nilai pasar Impact BioMedical
Analisis fundamental perusahaan:impactbiomedinc.com, IBO

This indicator synthesizes the aggregate expectations of investment banks regarding the asset's fair value, filtering out short-term market volatility to identify the long-term valuation vector. By analyzing the average target price level, an investor assesses the growth potential, which for the venture business of Impact BioMedical Inc. (IBO) is complicated by a lack of stable revenue and unpredictable cash flows due to high R&D expenditures.

Pesaing Impact BioMedical Inc

Target median analis haleon.com|Prakiraan konsensus analis KVUE (Kenvue)|Verona Pharma PLC - Bagan rega target|MENS - Bagan rega target|Rata-rata rega prakiraan Ligand Corp|Amneal Pharmaceuticals (AMRX) - Bagan rega target|Bagan tingkat prakiraan PRGO (perrigo.com)|ALVO (Alvotech SA) - Prakiraan konsensus analis|LQDA: Konsensus nilai wajar|Prakiraan konsensus analis GLPG|Prakiraan konsensus analis ANI Pharmaceuticals Corp (ANIP)|Bagan rega target MannKind Corporation MNKD|Konsensus nilai wajar AMPH|PCRX - Bagan rega target|ARS Pharmaceuticals Inc (SPRY) - Target konsensus|TBPH: Prakiraan konsensus analis|Aquestive Corp (AQST) - Prakiraan konsensus analis|Target konsensus SCPH|TECX: Konsensus nilai wajar|Bagan rega target Tonix Pharmaceuticals Holding Corp. (TNXP)|SXTC - Rata-rata rega prakiraan|Eupraxia Pharmaceuticals Inc. - Target konsensus|Rega prakiraan analis BHST (BioHarvest Sciences Inc)|eXoZymes Inc - Prakiraan konsensus analis|Konsensus nilai wajar ORMP (Oramed Pharmaceuticals)|ENTX: Prakiraan konsensus analis|Rata-rata rega prakiraan MindWalk Holdings, Inc. (HYFT)|Bagan rega target ABVC BioPharma Inc|CPIX: Konsensus nilai wajar|Prakiraan konsensus analis QNTM|Target median analis fibrogen.com|Bagan rega target Telomir Pharmaceuticals, Inc. TELO|RANI - Target konsensus|SNYR - Bagan rega target|Bagan tingkat prakiraan RLYB|LEXX: Prakiraan konsensus analis|pulmatrix.com (PULM) - Prakiraan konsensus analis|PTHL (Pheton Holdings Limited) - Prakiraan konsensus analis|Target konsensus Aptorum (APM)|Target konsensus LYRA (Lyra Therapeutics, Inc)|Rega prakiraan analis TNFA|cbdMD - Target konsensus|Konsensus nilai wajar PRFX|Auris Medical - Prakiraan konsensus analis|LIPO: Bagan rega target|OPTN: Prakiraan konsensus analis|PIRS - Target median analis|Bagan rega target Procaps Group S.A.|Rata-rata rega prakiraan petrospharma.com PTPI|Bagan rega target Qilian International Holding (QLI)|Target konsensus Acelyrin Inc. SLRN|Prakiraan konsensus analis TFFP (TFF Pharma)